期刊文献+

中药复方NZ制剂中黄芩苷薄层鉴别及含量测定 被引量:4

TLC identification and determination of baicalin in NZ compound preparations
下载PDF
导出
摘要 目的:建立中药复方NZ制剂中黄芩苷的薄层鉴别和含量测定方法。方法:采用TLC对组方中黄芩苷进行定性鉴别,同时利用HPLC对其进行含量测定。结果:薄层色谱斑点分离效果较好(R_f=0.35),斑点显色清晰且无干扰、重复性好;黄芩苷在0.313 5~1.567 4μg·mL^(-1)范围内线性关系良好,本批次中药复方NZ制剂中黄芩苷含量为10.90mg·g^(-1)。结论:该方法可用于复方NZ制剂中黄芩苷的定性鉴别和含量测定。 Objective:To establish the methods for TLC identification and content determination of baicalin in NZ compound preparations. Methods:Baicalin in NZ compound preparations was identified by TLC, and the content of baicalin was detected by HPLC. Results: The re- sults indicated that the bands in the TLC were clear withoutinterference (Rf=0.35). Baicalinin the NZ compound preparations curve showed good linearity in the range of 0. 313 488~ 1. 567 44μg · mL^-1. The content of baicalin in this batch is 10.90mg · g^-. Conclusion: This qualitative and quantitative method can be used for the quality control of NZ compound preparations.
出处 《亚太传统医药》 2017年第7期41-43,共3页 Asia-Pacific Traditional Medicine
关键词 中药复方NZ制剂 黄芩苷 薄层鉴别 含量测定 NZ Compound Preparations Baicalin TCL Determination
  • 相关文献

参考文献1

二级参考文献10

共引文献9

同被引文献46

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部